WISE CVD - Continuation (WISE HFpEF)

Abroad (travel likely)Recruiting

Conditions

Microvascular Coronary Dysfunction · Cardiovascular Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cedars-Sinai Women's Heart Center, Los Angeles, California, United States
Contact: Study coordinator (Fatima Bataz) · fatima.bataz@cshs.org · 310-248-7888
Contact: Study coordinator (BSWHC Research, MS) · bswhc.research@cshs.org · 310-423-9666
Contact: Principal Investigator (C. Noel Bairey Merz, MD, FACC)

Study leads

C. Noel Bairey Merz, MD, FACC
Principal Investigator
Cedars-Sinai Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

Angina Pectoris · Myocardial Ischemia · Heart Diseases

Abroad (travel likely)Recruiting

New Haven, United States · Cincinnati, United States

Non-invasive Microvascular Assessment in Individuals at High Risk of Cardiovascular Disease From the SCAPIS2 Study

Cardiovascular Diseases · Microvascular Complications

Abroad (travel likely)Recruiting

Stockholm, Sweden

Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility Study

Microvascular Coronary Dysfunction · Microvascular Angina · Coronary Microvascular Dysfunction (CMD)

Abroad (travel likely)Recruiting

Bath, United Kingdom · Bristol, United Kingdom

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

Coronary Artery Disease · Coronary Microvascular Dysfunction · Overweight or Obesity

Abroad (travel likely)RecruitingPHASE4

Copenhagen, Denmark · Gentofte Municipality, Denmark